Pathway Genomics will sell its tests at Walgreens.
A clinical trial of its drug for combating the afflictions of aging has been suspended.
Bizarre creations revealed at a synthetic bio conference.
A drug designed to fix the molecular defects in fragile X helps some patients.
Early adopters of personal genome sequencing gather to reflect on what we need to do to move the field forward.
Biological time is best described by a two-dimensional surface that takes the shape of a second order helix, says a new theory.
In honor of "DNA Day," personal genomics company 23andMe is offering a $99 test.
Neuroscientists discover a new way to determine the information content of neural spike trains
A former sequencing executive and his family have their genomes sequenced.
23andMe's consumer-based approach to research seems to be working.